Publication Information

{'id': 'https://openalex.org/W3211776566', 'doi': 'https://doi.org/10.1158/1538-7445.panca21-pr-004', 'title': 'Abstract PR-004: Inhibition of focal adhesion kinase (FAK) improves pancreatic ductal adenocarcinoma’s response to immunotherapy by targeting cancer stem cells (CSCs)', 'display_name': 'Abstract PR-004: Inhibition of focal adhesion kinase (FAK) improves pancreatic ductal adenocarcinoma’s response to immunotherapy by targeting cancer stem cells (CSCs)', 'publication_year': 2021, 'publication_date': '2021-11-15', 'ids': {'openalex': 'https://openalex.org/W3211776566', 'doi': 'https://doi.org/10.1158/1538-7445.panca21-pr-004', 'mag': '3211776566'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.panca21-pr-004', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5109567068', 'display_name': 'Yezi Zhu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I86519309', 'display_name': 'The University of Texas at Austin', 'ror': 'https://ror.org/00hj54h04', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I86519309']}, {'id': 'https://openalex.org/I1305023659', 'display_name': 'Livestrong Foundation', 'ror': 'https://ror.org/04ndvz759', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1305023659']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yezi Zhu', 'raw_affiliation_strings': ['1LIVESTRONG Cancer Institute, Dell Medical School, UT Austin, Austin, TX,'], 'affiliations': [{'raw_affiliation_string': '1LIVESTRONG Cancer Institute, Dell Medical School, UT Austin, Austin, TX,', 'institution_ids': ['https://openalex.org/I86519309', 'https://openalex.org/I1305023659']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076040661', 'display_name': 'Lyndsey Sandow', 'orcid': 'https://orcid.org/0009-0008-8149-5442'}, 'institutions': [{'id': 'https://openalex.org/I165690674', 'display_name': 'Oregon Health & Science University', 'ror': 'https://ror.org/009avj582', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I165690674']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lyndsey Sandow', 'raw_affiliation_strings': ['2Oregon Health & Science University, Portland, OR.'], 'affiliations': [{'raw_affiliation_string': '2Oregon Health & Science University, Portland, OR.', 'institution_ids': ['https://openalex.org/I165690674']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5027419360', 'display_name': 'William Matsui', 'orcid': 'https://orcid.org/0000-0002-3088-0964'}, 'institutions': [{'id': 'https://openalex.org/I1305023659', 'display_name': 'Livestrong Foundation', 'ror': 'https://ror.org/04ndvz759', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1305023659']}, {'id': 'https://openalex.org/I86519309', 'display_name': 'The University of Texas at Austin', 'ror': 'https://ror.org/00hj54h04', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I86519309']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'William Matsui', 'raw_affiliation_strings': ['1LIVESTRONG Cancer Institute, Dell Medical School, UT Austin, Austin, TX,'], 'affiliations': [{'raw_affiliation_string': '1LIVESTRONG Cancer Institute, Dell Medical School, UT Austin, Austin, TX,', 'institution_ids': ['https://openalex.org/I1305023659', 'https://openalex.org/I86519309']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.208, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.471022, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 67, 'max': 72}, 'biblio': {'volume': '81', 'issue': '22_Supplement', 'first_page': 'PR', 'last_page': '004'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9946, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9946, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9917, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10336', 'display_name': 'Cancer Cells and Metastasis', 'score': 0.989, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/clonogenic-assay', 'display_name': 'Clonogenic assay', 'score': 0.49037504}], 'concepts': [{'id': 'https://openalex.org/C154317977', 'wikidata': 'https://www.wikidata.org/wiki/Q376266', 'display_name': 'Cytotoxic T cell', 'level': 3, 'score': 0.80901814}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.69915813}, {'id': 'https://openalex.org/C55427017', 'wikidata': 'https://www.wikidata.org/wiki/Q1638475', 'display_name': 'Cancer stem cell', 'level': 3, 'score': 0.6479907}, {'id': 'https://openalex.org/C2780210213', 'wikidata': 'https://www.wikidata.org/wiki/Q212961', 'display_name': 'Pancreatic cancer', 'level': 3, 'score': 0.5446978}, {'id': 'https://openalex.org/C117262875', 'wikidata': 'https://www.wikidata.org/wiki/Q5135057', 'display_name': 'Clonogenic assay', 'level': 3, 'score': 0.49037504}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.43837237}, {'id': 'https://openalex.org/C2776107976', 'wikidata': 'https://www.wikidata.org/wiki/Q1786433', 'display_name': 'Tumor microenvironment', 'level': 3, 'score': 0.42543018}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.42340797}, {'id': 'https://openalex.org/C96232424', 'wikidata': 'https://www.wikidata.org/wiki/Q4118072', 'display_name': 'Cancer cell', 'level': 3, 'score': 0.41087794}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.3650176}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.36401993}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.35650486}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.30855924}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.23474279}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.17554745}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.16986609}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C3020616263', 'wikidata': 'https://www.wikidata.org/wiki/Q1216998', 'display_name': 'Tumor cells', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.panca21-pr-004', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.82, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4322720888', 'https://openalex.org/W4296613612', 'https://openalex.org/W4200022043', 'https://openalex.org/W3193904228', 'https://openalex.org/W2884525857', 'https://openalex.org/W2413364007', 'https://openalex.org/W2347271642', 'https://openalex.org/W2112727616', 'https://openalex.org/W2034722665', 'https://openalex.org/W2022458244'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Pancreatic': [2, 502], 'ductal': [3, 481], 'adenocarcinoma': [4], '(PDAC)': [5], 'is': [6, 87, 297, 406], 'one': [7], 'of': [8, 24, 40, 55, 77, 132, 147, 161, 191, 197, 222, 237, 260, 282, 329, 413, 428, 433, 450, 474, 495], 'the': [9, 38, 61, 75, 130, 145, 151, 154, 195, 220, 258, 367, 411, 425, 431, 448, 496], 'most': [10, 32], 'lethal': [11], 'cancers': [12], 'with': [13, 34, 211, 266, 299, 408], 'a': [14, 188, 453], '5-year': [15], 'survival': [16], 'rate': [17], 'less': [18], 'than': [19], '10%.': [20], 'Current': [21], 'therapies': [22], 'consisting': [23], 'cytotoxic': [25, 138, 157, 175, 212, 231, 315, 338, 388], 'chemotherapeutic': [26], 'agents': [27], 'are': [28, 113, 312, 384], 'not': [29, 46, 88, 332], 'effective': [30], 'in': [31, 79, 216, 224, 272, 291, 351, 363, 394, 410, 416, 435, 441, 463], 'patients': [33], 'metastatic': [35, 116], 'PDAC,': [36], 'and': [37, 67, 92, 108, 118, 141, 153, 209, 234, 244, 250, 275, 354, 391, 430], 'impact': [39, 146], 'new': [41], 'strategies,': [42], 'including': [43, 104, 123, 135], 'immunotherapies,': [44], 'has': [45], 'been': [47], 'established.': [48], 'Previous': [49], 'studies': [50], 'have': [51, 380], 'shown': [52], 'that': [53, 185, 263, 310, 382, 405], 'inhibition': [54, 149, 328, 393], 'focal': [56, 475], 'adhesion': [57, 476], 'kinase': [58, 477], '(FAK)': [59, 478], 'modulates': [60], 'PDAC': [62, 98, 133, 162, 292, 335, 356], 'immunosuppressive': [63], 'tumor': [64, 81, 106, 170, 323, 369, 437], 'microenvironment': [65], '(TME),': [66], 'sensitizes': [68], 'tumors': [69], 'to': [70, 85, 120, 137, 156, 173, 229, 314, 321, 337, 346, 366, 386, 400, 447, 459, 484], 'immune': [71], 'checkpoint': [72], 'blockade.': [73], 'However,': [74], 'role': [76, 432], 'FAK': [78, 96, 148, 168, 223, 253, 278, 283, 330, 376, 392, 451], 'regulating': [80, 225, 436], 'cell': [82, 159, 203, 294, 340, 348, 357, 403], 'intrinsic': [83, 171, 438], 'resistance': [84, 119, 172, 440], 'immunotherapy': [86, 439, 461, 485], 'well': [89], 'understood.': [90], 'We': [91, 218, 255, 325, 379], 'others': [93], 'previously': [94], 'demonstrated': [95, 359, 381], 'regulates': [97, 169], 'cancer': [99, 202, 488], 'stem': [100, 489], 'cells': [101, 182, 215, 227, 233, 268, 274, 317, 336, 370, 399, 490], '(CSCs)': [102, 491], 'activity': [103, 160, 284, 287, 319, 331, 404], 'self-renewal,': [105], 'initiation,': [107], 'drug': [109], 'resistance.': [110], 'These': [111], 'CSCs': [112, 136, 238, 276, 286, 311, 345, 364, 383, 395, 429, 434, 458], 'responsible': [114], 'for': [115, 457], 'dissemination': [117], 'multiple': [121], 'therapies,': [122], 'immunotherapy.': [124], 'In': [125], 'this': [126], 'study,': [127], 'we': [128, 142, 178, 308], 'evaluated': [129], 'sensitivity': [131, 228], 'cells,': [134, 140, 177, 390], 'T': [139, 158, 176, 181, 232, 267, 316, 339, 347, 389, 402], 'also': [143, 256, 326, 343, 445], 'analyzed': [144, 219, 257], 'on': [150, 501], 'immunogenicity': [152, 427], 'response': [155, 483], 'CSCs.': [163], 'Methods:': [164], 'To': [165], 'understand': [166], 'how': [167], 'antigen-specific': [174, 230, 304, 387], 'utilized': [179], 'OT-I': [180, 214, 305], '(OT-I': [183], 'cells)': [184], 'specifically': [186], 'recognize': [187], 'peptide': [189], 'fragment': [190], 'ovalbumin': [192], '(ova)': [193], 'within': [194], 'context': [196], 'MHC-I.': [198], 'Mouse': [199], 'KPC': [200], 'pancreatic': [201, 480], 'lines': [204, 358], 'expressing': [205], 'ova': [206], 'were': [207], 'generated': [208], 'co-cultured': [210], 'CD8+': [213], 'vitro.': [217], 'effect': [221], 'bulk': [226, 273, 322, 368], 'clonogenic': [235], 'growth': [236], 'by': [239, 375, 486], 'flow': [240], 'cytometry,': [241], 'MTT': [242], 'assay': [243, 247], 'colony': [245, 289], 'formation': [246], 'using': [248], 'CRISPR-Cas9': [249], 'small': [251], 'molecule': [252], 'inhibitors.': [254], 'expression': [259, 362, 412], 'surface': [261], 'proteins': [262], 'mediate': [264], 'interactions': [265], '(class': [269], 'I': [270], 'MHC)': [271], 'after': [277], 'inhibition.': [279, 377], 'Results:': [280], 'Loss': [281], 'decreased': [285, 360], '(self-renewal,': [288], 'formation)': [290], 'mouse': [293, 355], 'lines,': [295], 'which': [296, 371], 'consistent': [298], 'our': [300], 'previous': [301], 'data.': [302], 'Using': [303], 'co-culture': [306], 'model,': [307], 'found': [309, 327], 'resistant': [313, 385], 'anti-tumor': [318, 401], 'compared': [320, 365], 'cells.': [324], 'only': [333], 'enhances': [334], 'activity,': [341], 'but': [342], 'sensitized': [344], 'killing.': [349], 'Studies': [350], 'both': [352], 'human': [353], 'MHC-I': [361], 'could': [372], 'be': [373], 'reversed': [374], 'Conclusion:': [378], 'can': [396], 'sensitize': [397], 'these': [398], 'associated': [407], 'changes': [409], 'factors': [414], 'involved': [415], 'antigen': [417], 'presentation.': [418], 'Our': [419, 443], 'study': [420], 'provides': [421], 'novel': [422, 454], 'insights': [423], 'into': [424], 'unique': [426], 'PDAC.': [442, 464], 'findings': [444], 'lead': [446], 'identification': [449], 'as': [452], 'therapeutic': [455], 'target': [456], 'improve': [460], 'efficacy': [462], 'Citation': [465], 'Format:': [466], 'Yezi': [467], 'Zhu,': [468], 'Lyndsey': [469], 'Sandow,': [470], 'William': [471], 'Matsui.': [472], 'Inhibition': [473], 'improves': [479], 'adenocarcinoma’s': [482], 'targeting': [487], '[abstract].': [492], 'In:': [493], 'Proceedings': [494], 'AACR': [497], 'Virtual': [498], 'Special': [499], 'Conference': [500], 'Cancer;': [503], '2021': [504], 'Sep': [505], '29-30.': [506], 'Philadelphia': [507], '(PA):': [508], 'AACR;': [509], 'Cancer': [510], 'Res': [511], '2021;81(22': [512], 'Suppl):Abstract': [513], 'nr': [514], 'PR-004.': [515]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3211776566', 'counts_by_year': [{'year': 2023, 'cited_by_count': 2}], 'updated_date': '2024-12-16T01:26:04.039352', 'created_date': '2021-11-22'}